What is BC Platforms?
Headquartered in Zurich, Switzerland, BC Platforms provides sophisticated healthcare data management and analytics services. The company specializes in the integration of genomics and clinical data, offering robust solutions that empower researchers and healthcare providers to unlock the potential of precision medicine. By facilitating the secure and efficient handling of high-dimensional biological data, BC Platforms enables its clients to accelerate drug discovery and improve patient outcomes. Its market position is defined by its ability to harmonize disparate data sources, a capability that has become increasingly vital as the global healthcare industry shifts toward data-driven, patient-centric care models.
How much funding has BC Platforms raised?
BC Platforms has raised a total of $48.4M across 5 funding rounds:
Debt
$1.7M
Series A
$1.7M
Series B
$10M
Series C
$15M
Other Financing Round
$20M
Debt (2016): $1.7M, investors not publicly disclosed
Series A (2016): $1.7M led by Boston Millennia Partners
Series B (2017): $10M supported by Tesi
Series C (2019): $15M featuring IQVIA, Tesi, and Debiopharm Innovation Fund
Other Financing Round (2022): $20M backed by Jolt Capital
Key Investors in BC Platforms
Jolt Capital
Jolt Capital is a private equity firm that specializes in growth-stage deeptech companies, focusing on sectors such as cybersecurity, semiconductors, and advanced materials.
IQVIA
IQVIA is a global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients.
Tesi
Tesi is a Finnish venture capital and private equity company that accelerates companies' success stories by investing in them directly and via funds.
What's next for BC Platforms?
Following the latest major strategic investment, BC Platforms is well-positioned to scale its operations and deepen its technological moat within the competitive health informatics landscape. The company is expected to leverage this capital to enhance its proprietary analytics engine, expand its footprint in international markets, and further integrate its solutions with global clinical research networks. As the demand for scalable, privacy-compliant genomic data solutions continues to rise, BC Platforms remains focused on driving innovation in personalized medicine, ensuring that its enterprise-grade infrastructure remains at the forefront of the digital health revolution.
See full BC Platforms company page
